According to @business, BillionToOne shares jumped 67% on their trading debut after the molecular diagnostics company raised 273.1 million dollars in an upsized initial public offering, source: Bloomberg. Bloomberg reported the IPO as upsized with proceeds of 273.1 million dollars and a first-day gain of 67 percent; the source did not mention any direct impact on cryptocurrency markets, source: Bloomberg.

According to @business, BillionToOne, a molecular diagnostics company, raised $273.1 million in an upsized US initial public offering during a US government shutdown that complicated the listing process, confirming the deal closed despite administrative constraints from the shutdown source: @business. The source characterizes the transaction as upsized and specifies the total proceeds of $273.1 million, while not providing pricing, valuation, ticker, allocation, or first-day trading performance details source: @business. The source does not reference any direct cryptocurrency market impact or digital asset linkage related to this IPO source: @business.